Caroline Litchfield
Director of Finance/CFO chez IMMUNE DESIGN CORP
Fortune : 7 M $ au 31/03/2024
Profil
Mme Caroline A. Litchfield est directrice financière et administratrice chez Immune Design Corp. et directrice financière et vice-présidente exécutive chez Merck & Co., Inc. Elle est membre du conseil d'administration d'Immune Design Corp. Mme Litchfield était auparavant employée en tant que directrice financière chez Merck Sharp & Dohme Ltd. Elle a obtenu son diplôme de premier cycle à l'université de Leicester.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
MERCK & CO., INC.
0,00% | 14/02/2024 | 50 908 ( 0,00% ) | 7 M $ | 31/03/2024 |
Postes actifs de Caroline Litchfield
| Sociétés | Poste | Début |
|---|---|---|
| IMMUNE DESIGN CORP | Director of Finance/CFO | - |
| MERCK & CO., INC. | Director of Finance/CFO | 01/04/2021 |
Anciens postes connus de Caroline Litchfield
| Sociétés | Poste | Fin |
|---|---|---|
| ORGANON & CO. | Director/Board Member | 31/05/2021 |
| FULFORD (INDIA) LIMITED | Director/Board Member | 30/01/2014 |
Organon Pharma (UK) Ltd.
 Organon Pharma (UK) Ltd. Pharmaceuticals: MajorHealth Technology Organon Pharma (UK) Ltd. develops and manufactures pharmaceuticals. It offers osteoarthritis pain treatment Arcoxia, cardiovascular medication Cozaar, HIV drug Crixivan and asthma treatment Singulair. It operates a research center specializing in the development of central nervous system disorder such as Alzheimer's disease, depression, anxiety and migrane. The company was founded in 1953 and is headquartered in Hoddesdon, the United Kingdom. | Director of Finance/CFO | 23/06/2009 |
Formation de Caroline Litchfield
| University of Leicester | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| ORGANON & CO. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Fulford (India) Ltd.
 Fulford (India) Ltd. Pharmaceuticals: MajorHealth Technology Fulford (India) Ltd. engages in the wholesale of pharmaceutical and medical goods. Its products include speciality health care and fertility, oncology, quadriderm, elocon, elosalic, dipsalic, and emolene. The company was founded on March 2, 1948 and is headquartered in Mumbai, India. | Health Technology |
Organon Pharma (UK) Ltd.
Organon Pharma (UK) Ltd. Pharmaceuticals: MajorHealth Technology Organon Pharma (UK) Ltd. develops and manufactures pharmaceuticals. It offers osteoarthritis pain treatment Arcoxia, cardiovascular medication Cozaar, HIV drug Crixivan and asthma treatment Singulair. It operates a research center specializing in the development of central nervous system disorder such as Alzheimer's disease, depression, anxiety and migrane. The company was founded in 1953 and is headquartered in Hoddesdon, the United Kingdom. | Health Technology |
Immune Design Corp.
 Immune Design Corp. Pharmaceuticals: MajorHealth Technology Immune Design Corp. is a clinical-stage immunotherapy company focused on cancer with in vivo approaches designed to enable the body's immune system to fight disease. It develops multiple product candidates from its discovery platforms, ZVex and GLAAS. The company was founded by Steven G. Reed and David Baltimore on February 20, 2008 and is headquartered in Kenilworth, NJ. | Health Technology |
